ESC 365 - SGLT2-inhibitors for HFpEF?

Open Access

SGLT2-inhibitors for HFpEF?

Session: Lessons from recent and ongoing heart failure trials

Topic: Basic Science

Speaker: Doctor B. Westenbrink (Groningen, NL)

Event: Heart Failure 2020

Congress Presentation

Add to my library

About the speaker

Doctor B Daan Westenbrink

University Medical Centre Groningen, Groningen (Netherlands (The))

4 presentations

0 follower

3 more presentations in this session

Neprilysin inhibition in HFpEF: is BNP involved?

Speaker: Professor A. Mebazaa (Paris, FR)

Anti-fibrotic therapies.

Speaker: Professor T. Thum (Hannover, DE)

Interleukin -1 inhibitors.

Speaker: Doctor A. Abbate (Charlottesville, US)

Access the full session

Lessons from recent and ongoing heart failure trials

Speakers: Doctor B. Westenbrink, Professor A. Mebazaa, Professor T. Thum, Doctor A. Abbate

About the event

Heart Failure 2020

23 May - 26 May 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources